TERT and central nervous system cancer: All three immune subtypes harbored grade 2, 3, and 4 gliomas (Fig. 2C), IDH mutant gliomas (Fig. 2D), 1p19q codeleted gliomas (Fig. 2E), and TERT promoter mutated gliomas (Fig. 2F).